Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
Author:
Affiliation:
1. Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
2. Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Abstract
Funder
NIH/NCI
Leukemia and Lymphoma Society Translational Research Program
Publisher
American Association for the Advancement of Science (AAAS)
Subject
General Medicine
Reference27 articles.
1. Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
2. Reduced intensity allogeneic hematopoietic transplantation is an established standard of care for treatment of older patients with acute myeloid leukemia
3. Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)
4. Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial
5. Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222
Cited by 137 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systemic Multifunctional Nanovaccines for Potent Personalized Immunotherapy of Acute Myeloid Leukemia;Advanced Materials;2024-08-22
2. Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies;International Journal of Molecular Sciences;2024-07-09
3. Anti-Leukemic Effects Induced by Dendritic Cells of Leukemic Origin from Leukemic Blood Samples Are Comparable under Hypoxic vs. Normoxic Conditions;Cancers;2024-06-28
4. PIKfyve, expressed by CD11c-positive cells, controls tumor immunity;Nature Communications;2024-06-28
5. Dendritic cell vaccination strategy for the treatment of acute myeloid leukemia: a systematic review;Cytotherapy;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3